Trade Evotec AG - EVT CFD
Add to favourite- Summary
- Historical Data
Spread | 0.115 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.020029% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.002193% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Germany | ||||||||
Commission on trade | 0% |
Prev. Close | 8.915 |
Open | 8.835 |
1-Year Change | -51.87% |
Day's Range | 8.605 - 8.835 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 2, 2024 | 8.915 | 0.155 | 1.77% | 8.760 | 8.975 | 8.660 |
Nov 29, 2024 | 8.735 | -0.260 | -2.89% | 8.995 | 9.115 | 8.680 |
Nov 28, 2024 | 9.070 | -0.020 | -0.22% | 9.090 | 9.230 | 9.030 |
Nov 27, 2024 | 9.130 | -0.020 | -0.22% | 9.150 | 9.450 | 8.990 |
Nov 26, 2024 | 8.990 | -0.120 | -1.32% | 9.110 | 9.110 | 8.765 |
Nov 25, 2024 | 9.020 | 0.470 | 5.50% | 8.550 | 9.340 | 8.490 |
Nov 22, 2024 | 8.340 | -1.565 | -15.80% | 9.905 | 9.960 | 7.855 |
Nov 21, 2024 | 9.980 | 0.130 | 1.32% | 9.850 | 10.075 | 9.575 |
Nov 20, 2024 | 9.895 | 0.330 | 3.45% | 9.565 | 10.195 | 9.510 |
Nov 19, 2024 | 9.665 | -0.640 | -6.21% | 10.305 | 10.345 | 9.200 |
Nov 18, 2024 | 10.405 | 0.020 | 0.19% | 10.385 | 10.475 | 10.185 |
Nov 15, 2024 | 10.335 | -0.070 | -0.67% | 10.405 | 10.595 | 9.795 |
Nov 14, 2024 | 8.605 | 0.105 | 1.24% | 8.500 | 8.645 | 8.410 |
Nov 13, 2024 | 8.500 | 0.385 | 4.74% | 8.115 | 8.685 | 8.115 |
Nov 12, 2024 | 8.135 | -0.900 | -9.96% | 9.035 | 9.130 | 8.135 |
Nov 11, 2024 | 8.765 | 0.710 | 8.81% | 8.055 | 9.665 | 8.055 |
Nov 8, 2024 | 7.525 | -0.365 | -4.63% | 7.890 | 8.110 | 7.525 |
Nov 7, 2024 | 7.975 | 1.005 | 14.42% | 6.970 | 7.995 | 6.870 |
Nov 6, 2024 | 7.165 | -0.145 | -1.98% | 7.310 | 7.560 | 6.875 |
Nov 5, 2024 | 8.390 | 0.145 | 1.76% | 8.245 | 8.525 | 7.865 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Evotec Company profile
About Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Evotec SE revenues increased 20% to EUR431M. Net income increased from EUR5.8M to EUR247M. Revenues reflect EVT Execute segment increase of 22% to EUR329M, EVT Innovate segment increase of 36% to EUR101.9M, United States segment increase of 32% to EUR142.9M, Others segment increase of 30% to EUR47.5M, United Kingdom segment increase of 8% to EUR47.2M.
Industry: | Biotechnology & Medical Research (NEC) |
Essener Bogen 7
HAMBURG
HAMBURG 22419
DE
News
Silver price forecast 2025 and beyond: Third party price target
Rising interest rates and a strong dollar pushed silver to a two-year last September, but what lies ahead?
16:00, 3 December 2024Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
16:41, 28 November 2024Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com